Mycophenolate (Surface Ophthalmics)

N/A

Report date: 2024/04/16 10:50:55
First In Class

Base Information

Drug NameMycophenolate (Surface Ophthalmics)
Drug Alias NameMycosolSurf-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionB cells modulatorsT lymphocytes modulators
TargetsUpdating
Therapy Area/IndicationsDry Eye Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSurface Ophthalmics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSurface Ophthalmics Inc
Inactive CompaniesN/A
Active IndicationsDry Eye Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A